Pulmonary function studies in children treated by chemoradiotherapy and stem cell transplantation

Pediatric Blood and Cancer

Volumn 51, Issue 5, 2008, Pages 684-688

  Efrati, Ori ^a,b   Toren, Amos ^a   Duskin, Hadar ^a   Modan Moses, Dalit ^a   Bielorai, Bella ^a   Goldstein, Gal ^a   Churi, Chaim ^a   Vilozni, Daphna ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Acute lymphoblastic leukemia; Hodgkin lymphoma; Lung function tests; Stem cell transplantation

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; BRONCHODILATING AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ANTIBIOTIC THERAPY; ARTICLE; BRONCHIOLITIS OBLITERANS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL RESIDUAL CAPACITY; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; LUNG FUNCTION TEST; LUNG INFECTION; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; PATIENT MOBILITY; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SOLID TUMOR; SPIROMETRY; STEM CELL TRANSPLANTATION; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRONCHIOLITIS OBLITERANS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LUNG; MALE; NEOPLASMS; RADIOTHERAPY; RESPIRATORY FUNCTION TESTS; STEM CELL TRANSPLANTATION;

EID: 52249111127     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21722     Document Type: Article

References (40)

1. Ries LAG, Smith MA, Gurney JG, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, SEER Program, 1999.
2. Nysom K, Holm K, Hertz H, et al. Risk factors for reduced pulmonary function after malignant lymphoma in childhood. Med Pediatr Oncol 1998;30:240-248.
3. Pui CH. Childhood leukemias. N Engl J Med 1995;332:1618-1630.
4. Villani F, Viola G, Vismara C, et al. Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease. Anticancer Res 2002;22:2403-2408.
5. Fulgoni P, Zoia MC, Corsico A, et al. Lung function in survivors of childhood acute lymphoblastic leukemia. Chest 1999;116:1163-1167.
6. Ho VT, Weller E, Lee SJ, et al. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001;7:223-232.
7. Mertens AC, Yasui Y, Liu Y, et al. Survivor Study. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the survivor study. Cancer 2002;95:2431-2441.
8. Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 2001;13:242-248.
9. Fryer CJ, Fitzpatrick PJ, Rider WD, Poon P. Radiation pneumonitis: Experience following a large single dose of radiation. Int J Radiat Oncol Biol Phys 1978;4:931-936.
10. Jakacki RI, Schramm CM, Donahue BR, et al. Restrictive lung disease following treatment for malignant brain tumors: A potential late effect of craniospinal irradiation. J Clin Oncol 1995;13:1478-1485.
11. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Survivor Study. J Clin Oncol 2001;19:3163-3172.
12. O'Driscoll BR, Hasleton PS, Taylor PM, et al. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990;323:378-382.
13. O'Driscoll BR, Kalra S, Gattamaneni HR, et al. Late carmustine lung fibrosis. Age at treatment may influence severity and survival. Chest 1995;107:1355-1357.
14. Fanfulla F, Locatelli F, Zoia MC, et al. Pulmonary complications and respiratory function changes after bone marrow transplantation in children. Eur Respir J 1997;10:2301-2306.
15. Clark JG, Hansen JA, Hertz MI, et al. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993;147:1601-1606.
16. Breuer R, Lossos IS, Berkman N, Or R. Pulmonary complications of bone marrow transplantation. Respir Med 1993;87:571-579.
17. Schultz KR, Green GJ, Wensley D, et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994;84:3212-3220.
18. Kaplan EB, Wodell RA, Wilmott RW, et al. Late effects of bone marrow transplantation on pulmonary function in children. Bone Marrow Transplant 1994;14:613-621.
19. Lund MB, Brinch L, Kongerud J, Boe. J. Lung functions 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophamide. Eur Respir J 2004;23:901-905.
20. Frisk P, Arvidson J, Bratteby L-E, et al. Pulmonary function after bone marrow transplantation in children: A long term prospective study. Bone Marrow Transplant 2004;33:645-650.
21. Cerveri I, Zoia MC, Fulgoni P, et al. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax 1999;54:131-135.
22. Lark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med 1989;111:368-376.
23. Aurora P, Eeigen H, Artes B, Davis S, Markus J, Stocks J, Tepper R, Vilozni D. Spirometry in preschool children. ATS/ERS joint working group on infant and young children pulmonary function testing. Am J Respir Crit Care Med 2007;175:1310-1313.
24. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J Suppl 1993;16:5-40.
25. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): Recommendations for a standard technique, 1995 update. Am J Respir Crit Care Med 1995;152:2185-2198.
26. Bruno B, Souillet G, Bertrand Y, et al. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre. Bone Marrow Transplant 2004;31:143-147.
27. Ringden O, Remberger M, Ruutu T, et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: Long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic bone marrow transplantation group. Blood 1999;93:2196-2201.
28. Prince DS, Wingard JR, Saral R, et al. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest 1989;96:301-306.
29. McDonald GB, Sullivan KM, Schuffler MD, et al. Esophageal abnormalities in chronic graft-versus-host disease in humans. Gastroenterology 1981;8:914-921.
30. Curtis DJ, Smale A, Thien F, et al. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1995;16:169-173.
31. Cerveri I, Fulgoni P, Giorgiani G, et al. Lung function abnormalities after bone marrow transplantation in children. Chest 2001;120:1900-1906.
32. Kaplan EB, Wodell RA, Wilmott RW, et al. Late effects of bone marrow transplantation on pulmonary function in children. Bone Marrow Transplant 1994;14:613-621.
33. Quigley PM, Yeager AM, Loughlin GM. The effects of bone marrow transplantation on pulmonary function in children. Pediatr Pulmonol 1994;18:361-367.
34. Cooper JA Jr, White DA, Matthay RA. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis 1986;133:321-340.
35. Barrett A. Realationship of irradiation to pulmonary complications. Exp Hematol 1984;12:6-7.
36. Leiper AD, Stanhope R, Lau T, et al. The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol 1987;67:419-426.
37. Socie G, Curtis RE, Deeg HJ, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000;18:348-357.
38. Weiner DJ, Maity A, Carlson CA, Ginsberg JP. Pulmonary function abnormalities in children treated with whole lung irradiation. Pediatr Blood Cancer 2006;46:222-227.
39. Arvidson J, Bratteby LE, Carlson K, et al. Pulmonary function after autologous bone marrow transplantation in children. Bone Marrow Transplant 1994;14:117-123.
40. Shaw NJ, Tweeddale PM, Eden OB. Pulmonary function in childhood leukaemia survivors. Med Pediatr Oncol 1989;17:149-154.